Position: President, Oncology Hospital, Foshan Fosun Chancheng Hospital
Academic position:
• President, Oncology Hospital, Foshan Fosun Chancheng Hospital
• PhD in Biomedical Engineering and Medical Physics
• Chinese-American medical physics expert.
• Clinical Associate Professor at Drexel University
• Co-founder of the CyberKnife Center in Philadelphia, USA, and long-serving Chief Medical Physicist
• Chief Medical Physicist at Delaware County Hospital and Alliance Oncology (the third-largest precision radiation therapy provider in North America)
• Clinical Associate Professor at Drexel University (USA), Distinguished Professor at Fudan University (Shanghai), Visiting Professor at Duke Kunshan University, and editorial board member for multiple professional journals.
• Serves as a board member and Chair of the Physics Committee for the North American Radiosurgery Association (NARA); long-term leader and chair of the International Radiosurgery Annual Meeting; board member of the AERO User Association
• Participated in the development of various standards and guidelines, including practice standards for radiosurgery physicists in North America, physics specifications for CyberKnife systems in North America, and white papers on radiosurgery physics in North America.
• Former Board Member (Jan 2013 – Mar 2021) and Lifetime Member, International Radiosurgery Society
• Former Chair of the Physics Committee, International Radiosurgery Society (Jan 2013 – Mar 2021)
• Currently serves as Co-chair of the China Committee / Member of the Certification Committee
• Board Member, Radiation Oncology Exchange Association (May 2012–present)
• Member of Task Group 135 (CyberKnife Quality Assurance Guidelines) of the American Association of Physicists in Medicine (AAPM).
• Member of Task Group 277 (Practice Guidelines for Radiosurgery Physics) of the American Association of Physicists in Medicine (AAPM).
• Co-Director, AAPM-RSS 2015 SBRT School
• Editorial Board Member, *Journal of Applied Clinical Medical Physics* (June 2013–Present)
• Member of the Editorial Board, *Journal of Radiation Therapy* (2012–present)
Areas of Expertise
His core expertise lies in precision radiotherapy, radiosurgery, and the radiobiology of hypofractionated tumor treatment.He is highly proficient in CyberKnife technology, which enables image-guided, non-invasive, bloodless, and painless stereotactic radiotherapy for tumors throughout the body—including primary and metastatic brain tumors, head and neck cancers, lung cancer, liver cancer, and pancreatic cancer.Furthermore, he pioneered the Stereotactic Central Ablative Radiation Therapy (SCART) technique.Based on the principles of Stereotactic Body Radiation Therapy (SBRT) and Spatially Fractionated Radiation Therapy (SFRT), SCART utilizes high-precision targeting to deliver an ablative, high dose of radiation to the tumor's core while minimizing the dose to the periphery. This achieves an innovative treatment model characterized by "core eradication and peripheral control."Clinical studies indicate a tumor control rate of nearly 95% three months post-treatment, offering a new, non-invasive, and highly effective therapeutic option for patients with large tumors who are ineligible for surgery or unresponsive to conventional radiotherapy and chemotherapy.
